International Conference on
Genetic Engineering
DATE
August 18-19, 2025
Venue
Hilton Garden Inn Zurich Limmattal, Switzerland
- Abstract Submission Open Started
- Early Bird Registration Start: November 01, 2024
About Genetic Engineering Conference :
The Genetic Engineering Conference explore the current developments and advances in genetic modification technologies. CRISPR-Cas9, gene editing, synthetic biology and genome sequencing are some of the key subjects. Attendees will learn about innovate applications in biotechnology, medicine and agriculture, with concentrate on improving human health, increasing crop yields and reducing disorder. Experts from education, industry and research institutions will speak on innovations in genetic modification, ethical issues and future plans. The Genetic Engineering events provides networking opportunities for professionals in genomics, biopharmaceuticals and molecular biology, with the goal of motivating collaboration and promoting innovation in genetic engineering for a more sustainable future.
Be part of the Genetic Engineering Conference of global Biochemistry events in Zurich, Switzerland on August 18-19, 2025, hosted by Stripe Conferences. Explore the latest innovations and advances in biochemistry conference and genetic engineering conference, interact with leading experts and learn valuable insights into the current challenges and solutions shaping these fields. showcase your research, expand your knowledge and connect with professionals from the medical, biotech, pharmaceutical and healthcare organizations. Signup for this exceptional opportunity to connect with a world community of biotechnologists, researchers and instructors. Sign up today!
The Genetic Engineering meeting attracts researchers in education and industry, educators, trainees and students from all around the world. It offers exceptional opportunities for communicating, networking and recruiting. We look forward to an inspiring and Innovative Biochemistry conference filled with meaningful connections.
Scientific Session
In order to improve treatment outcomes, gene editing for cancer therapy uses technologies such as CRISPR/Cas9 to change genes in immune cells or cancer cells. This method can target sure changes in DNA that fuel tumor growth, inhibit cancer-promoting genes, or improve the immune system’s capacity to identify and eliminate cancerous cells. Certain tumors may be treated using methods like genetically modifying T cells to express chimeric antigen receptors (CAR-T cells). Before returning a patient’s cells back into the body, gene editing can also be employed to fix genetic flaws in those cells. While its potential, there are still issues to be resolved, including as delivery strategies, side effects, and moral dilemmas.
Related Conferences:
Genetic Engineering Conference 2025 | Innovative Biochemistry Conference 2025|Global Biochemistry events |
he accuracy and efficiency of gene editing has been greatly improved by recent advancements in instruments and software. More precise and focused changes to genes are now possible thanks to enhanced algorithms available on cutting-edge software platforms for creating guide RNAs and forecasting off-target consequences. High-fidelity variations of tools like CRISPR/Cas9 have been designed to minimize unwanted changes. Novel Cas proteins with alternate editing capabilities, like as Cas12 and Cas13, are examples of innovations. Large-scale experiments are also made possible by automated methods and high-throughput screening technologies, which simplify the editing process.
These developments improve both the creation and implementation of gene editing techniques, which makes research, therapeutic applications, and possible clinical interventions more successful. The Genetic Engineering conference focus on Developments in Gene Editing Software and Tools.
The success rate and selection of conveying genetic information into target cells have been improved by developments in gene delivery technologies. Viral vectors, including as lentiviruses and adeno-associated viruses (AAVs), have been developed as new techniques for better targeting and safety. Non-viral methods encapsulate and safeguard genetic material using liposomes and dendrimers, such as nanoparticle-based delivery systems. Accurate delivery mechanisms are provided by advances in microinjection and electroporation techniques. Also, specific gene expression and controlled release are made possible by developments in biomaterials and intelligent delivery systems.
These advancements are essential for enhancing the efficacy of genetic cures in research and clinical settings, as well as for optimizing gene therapies.These advancements are highlighted in the Genetic Engineering Conference .
Biotechnology and genetic research have been transformed by developments in DNA synthesis methods. Complex genetic engineering projects are made easier by the rapid and economical production of individual DNA sequences made possible by high-throughput synthesis techniques. Accuracy and affordability have been greatly enhanced by innovations like automated DNA synthesis and next-generation sequencing. Extended and complex DNA sequences can be constructed with reduced errors thanks to enhanced error-correction methods and improved synthesis chemicals.
Furthermore, whole synthetic genomes can now be created because to innovative techniques like synthetic biology and automated design tools. These developments are pushing the boundaries of genetic engineering by speeding up the creation of innovative treatments, biologics, and synthetic species.
With the help of the novel gene-editing technique, CRISPR/Cas9 enables the precise alteration to be made to DNA. This system has two major components: the Cas9 enzyme, which cuts DNA at specific locations rather like molecular scissors, and a guide RNA-the gRNA-which points Cas9 toward the target sequence. This may include the addition or removal of genetic material and the change in genetic material, all as a consequence of that precise cut. Recent improvements involve the development of more efficient CRISPR/Cas12 systems, applications in biotechnology, agriculture, medicine, and others, and more precise techniques with high-fidelity Cas9 variants. It is expected that these developments will accelerate research and treatment development based on such new trends.
Genetic engineering has transformative applications across diverse fields. In medicine, it enables gene therapy to treat genetic disorders and produces biopharmaceuticals like insulin and vaccines. In agriculture, it enhances crop traits such as resistance to pests and environmental stress, improving yield and sustainability.
Genetic engineering also advances industrial biotechnology by creating microorganisms that produce valuable chemicals, enzymes, and biofuels. Additionally, it contributes to environmental conservation through bioremediation, where engineered organisms break down pollutants. The technology’s versatility drives innovations in research, diagnostics, and therapeutics, addressing complex challenges and improving quality of life globally. Applications of Genetic Engineering is included in the international Biochemistry events.
In agricultural genetic engineering, the DNA of plants and animals is modified to produce desired features and increase yield. Crops with enhanced resistance to pests, diseases, and environmental challenges can be developed thanks to techniques like gene editing and transgenesis. Furthermore, changes in genes can improve shelf life, production, and nutritional content. Genetic engineering has a chance to improve feed efficiency, boost growth rates, and provide disease resistance in livestock. Because they increase food security and decrease the need for chemical inputs, these developments support sustainable agriculture. The application of genetic engineering in agriculture presents ethical and legal questions even with its potential. Genetic Engineering in Agriculture will be included in Genetic Engineering Conference.
The possible effects of genetic engineering on human health, the environment, and social norms are at the center of ethical and regulatory concerns. The long-term repercussions of genetic alterations are a concern, especially in relation to genetically modified organisms (GMOs) and human germline editing in agriculture. The morality of changing genetic material, particularly in humans and animals, as well as the consequences for biodiversity are topics of discussion in ethics. Global laws and regulations that prioritize public transparency, labeling, and safety assessments differ. To balance the potential risk and societal impact of genetic engineering with its benefits, ethical concerns and stringent control are essential. These problems are still evolving as the science advances.Ethical and Regulatory Issues
Venue Attraction
Hotel Services & Amenities
- Connecting Rooms
- Hot breakfast
- Free WiFi
- Concierge
- Non-smoking rooms
- Digital Key
- On-site restaurant
- Fitness center
- Express Mail
- Pet-friendly rooms
- Room service
- Meeting rooms
Registration
Speaker Registration
Oral Presentations
$745
Student Registration
Post Graduates
$395
Delegate Registration
Participant & Attendants
$795
Get In Touch
To learn more about our conferences and events, please get in touch with us. Join our extensive network of scientists, professional experts, and research scholars to stay informed and connected.
Address
16192 Coastal Highway Lewes, Delaware, USA 19958
Phone number
+1 630 768 1199
E-mail address
support@stripeconferences.com
Media Partners






CONTACT US
Frequently Asked Questions
The deadline for submitting abstracts for the Genetic Engineering conference is set by the event website, and specific guidelines are available online.
Hybrid models are frequently used in conferences, allowing attendees to attend in person or virtually. Check the official Genetic Engineering Conference page for updates.
Attendees can engage with global experts, learn about genetic engineering research, explore CRISPR technologies, and discuss ethical, regulatory, and industrial applications.
Attendees include researchers, scientists, academicians, industry professionals, students and policymakers interested in genetic engineering innovations and applications.